EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level



The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level



Pediatric Hematology and Oncology 28(8): 721-722




(PDF emailed within 0-6 h: $19.90)

Accession: 056316213

Download citation: RISBibTeXText

PMID: 21875319

DOI: 10.3109/08880018.2011.599051



Related references

Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn. Archivos Argentinos de Pediatria 107(2): 119-125, 2009

Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin. Journal of Pediatric Hematology/Oncology 24(8): 689-693, 2002

Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease. Pediatrics 90(5): 678-680, 1992

Hyporegenerative anemia associated with Rh hemolytic disease Lack of effect of treatment with recombinant erythropoietin. Pediatric Research 49(4 Part 2): 409A, April, 2001

Comparison between two treatment protocols with recombinant human erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-isoimmunization. La Pediatria Medica E Chirurgica 34(4): 186-191, 2012

Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment. Diseases of the Colon and Rectum 38(8): 896-897, 1995

Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization. Journal of Pediatric Hematology/Oncology 32(3): E95-101, 2010

Recombinant human erythropoietin may correct erythropoietin-deficient hyporegenerative anaemia in children given cardiac transplantation. British Journal of Haematology 88(3): 623-625, 1994

Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients?. Casopis Lekaru Ceskych 129(4): 113-115, 1990

Late hyporegenerative anemia of ABO isoimmunization. Pediatric Research 35(4 PART 2): 69A, 1994

Effectiveness of recombinant human erythropoietin in the treatment of transfusion dependent anemia in patients on chronic hemodialysis. Wiener Klinische Wochenschrift 99(24): 855-859, 1987

Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis. Wiener Klinische Wochenschrift 99(24): 855-859, 1987

Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. International Journal of Artificial Organs 17(4): 195-202, 1994

Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children. Pediatric Aids and HIV Infection 8(1): 4-11, 1997

Serum erythropoietin levels and recombinant human erythropoietin use for anemia in children with cancer. British Journal of Haematology 102(1): 336, July 1, 1998